INTRODUCTION
The title of this article is taken from a very famous and oft quoted saying of the AngloAmerican movie comedy duo, Laurel and Hardy. "NICE" is the abbreviation for the UK based National Institute for Health and Care Excellence which is an organisation targeted with the responsibility of improving outcomes for people using the NHS and other public health and social care services, in part by producing evidence-based guidance and advice for health, public health and social care practitioners (www. nice.org.uk). In 2011 NICE produced guidelines suggesting that the adoption of the Deltex CardioQ intra-operative flow (cardiac output, CO) monitor is: "supported by the evidence that in high risk surgery there is a reduction in postoperative complications, use of central venous catheters and in-hospital stay (with no increase in the rate of re-admission or repeat surgery) compared with conventional clinical assessment with or without invasive cardiovascular monitoring. The cost saving per patient, when the CardioQ-ODM is used instead of a central venous catheter in the peri-operative period, is about £1100 based on a 7.5-day hospital stay". (1) The advice was later extended to include all "flow monitors". This article will review the evidence behind this statement in 2017 and suggest that much more still needs to be done beyond the simple addition of flow or CO measurement to conventional anaesthesia monitoring to improve outcome of high risk surgical patients. Indeed, as we shall see, due to a lack of demonstrable benefit in recent trials, many opinion leaders are now suggesting abandonment of this new technology and consider it irrelevant. A NICE mess we have gotten into!
THE INCREASINGLY HIGH-RISK SUR-GICAL POPULATION
It was estimated that 1 million of the estimated 3 million operations carried out in the UK NHS in 2013 as part of the National Audit Project 5 (NAP5) survey on accidental awareness under general anaesthesia were on patients aged over 65. (2) In a recent Australian and New Zealand study, 5% of patients over 70 died within 30 days of surgery. (3) The "Reason" study investigators commented that "strategies are needed to reduce complications and mortality in older surgical patients". Strategies and protocols need to be guided by monitors not "recipe books" and we need to individualise patient care. (4) Anaesthetists must also recognise that deficiencies in intraoperative management may not produce immediate mortality but may set in motion pathological changes which are deleterious for long-term patient outcome. Multimodal monitoring (MMM) using CO but in combination with depth of anaesthesia and tissue oximetry as described in the article is an attempt to reduce those complications and overall mortality after high risk surgery, especially in the elderly. Two questions arise from these statistics: 1. What could account for such a high mortality after major surgery in the high risk, elderly patient? 2. Can we intervene to reduce the risk of mortality?
NEW MONITORING TECHNOLOGY AND ITS USE IN THE OPERATING ROOM
There have been very few advances in routine intraoperative monitoring in anaesthesia in the last 30 years since the clinical introduction of the pulse oximeter in 1984. The traces are taken from a LiDCOrapid monitor. This was employed at the same time as another flow monitor which was used to manage the case. The operation duration is over 10 hours (x axis on all 4 traces).
The top red trace is nominal cardiac output (nCO) with a starting value of approximately 7 lpm prior to induction indicated by the horizontal red line. As can be seen, during the majority of the procedure the nCO fell to around 3 lpm a <>60% drop.
The next green trace is systemic vascular resistance (SVR) which shows a considerable increase throughout the procedure from baseline shown by the horizontal black line. The next trace is blood pressure with systolic and diastolic indicated by the width of the trace and the mean arterial pressure in red. An horizontal yellow line has been drawn from the pre-induction value throughout the whole 10 hour procedue and shows that this value has been maintained at around 75mm Hg. The bottom trace shows the starting nominal stroke volume (nSV) in dark blue with a horizontal blue line drawn from the starting value of around 80 mls with the blue arrow showing that for the majority of the procedure the value is around 20 to 30 ml., again an <> 60 ml drop. The purple trace and horizontal line shows that heart rate (HR) is maintained throughout at around 60 bpm.
etomidate was mainly due to a fall in CO and not due to a fall in SVR. (19) Why do MAP and CO fall during anaesthesia? In studies of the causes of hypotension with ganglion blocking drugs it was found that it was mainly due to venodilation not a change in SVR. (20) Subjects with the greatest underlying venous tone were the elderly and anaemic and thus would suffer the greatest effects from venodilation on SV, CO and MAP. Does this apply to anaesthesia? Experiments in dogs showed that propofol produced an increase in venous capacitance due to venodilation (not peripheral arteriolar vasodilation). (21) Following venodilation the fall in MAP is due not only to falling preload, SV and CO with a consequent reduction in DO2 but also due to a shift of volume out of the arterial tree into the dilated venous compartment. (22) This mimics the effects of hypovolaemia. I believe venodilation is a key feature of anaesthesia that has been very little recognised. (22) The question is whether we should try to maintain MAP by restoring effective ve- 
Factors regulating cardiac output
Following the work of Guyton in the 50s, Wolff enumerated the factors controlling CO, DO2 and oxygen extraction. He pointed out that tissues (except skin and kidney) regulate (pull) their own flow and DO2 according to their metabolic demands and the heart responds to this oxygen demand by increasing output. (24) Post induction measurement of CO greatly underestimates the true resting CO/DO2 and therefore any intervention which is supposedly designed to "optimise stroke volume" (whatever that means) rather than maintain pre-induction CO/DO2 will be flawed and may result, as above, in unnecessary excess fluid and Na+ administration without improving outcome in high-risk patients. (6, 16, 25) Increasing CO artificially with fluids by a SV maximisation strategy to try and push supply oxygen to the tissues is looking at the problem the wrong way round. (24) This inevitably leads to excessive fluid administration and thence poor outcome. (16) Recommendation by NICE to add flow (CO) monitoring
As mentioned in the introduction, in 2011 NICE in the UK recommended the addition of flow monitoring using Doppler (Oesophageal Doppler, Deltex UK) technology for a distinct group of high-risk surgical patients undergoing particular surgical operations. (1) Even then, the guidance was questioned and argued over in editorials. (26, 27) Circulatory physiology during anaesthesia and the implications for adding CO monitoring
Before expecting the addition of a CO monitor to improve outcome it is important to be clear about the physiological effects of anaesthesia as mentioned above.
This not only includes distinguishing between venodilation and vasodilation but also the role of the intact endothelial glycocalyx layer (EGL) in controlling fluid exchange in the tissues. (28) This has important implications for surgical fluid management. (22) Excess fluids and Na+ to replace non-existent "third space loss" are not only unnecessary (15) but may actually damage the EGL directly by compression and distortion and also lead to an increase in atrial natriuretic peptide (ANP) which itself damages the layer. The implication is that "third space loss" may actually be precipitated by excess fluids! Does the use of flow monitoring and goal directed fluid therapy (GDFT) on its own when added to conventional monitoring improve outcome and reduce mortality? In a recent Cochrane collaboration review entitled "Perioperative increase in global blood flow to explicit defined goals and outcomes after surgery", the investigators noted that using this strategy did not decrease mortality. 
Conclusion
Although there is not overwhelming evidence to mandate the use of cerebral oxygen monitoring in major surgery I believe it is useful in carotid endarterectomy, shoulder surgery in the beach chair position, major thoracic and cardiac surgery and major abdominal and orthopaedic surgery in high risk patients. Figure 2 indicates why monitoring the effect of the anaesthetic on cortical suppression is important for high-risk patients yet may not be as important for fit and healthy patients. Looking along the x-axis from left to right, increasing anaesthetic concentration will inevitably lead to increasing cardiovascular depression and decreased DO2. This obviously has implications for build-up of oxygen debt, complications in the post-operative period and poor outcome. It also is likely to produce neuronal toxicity as the concentration of anaesthetic increases. (50) On the other hand, moving from right to left along the x-axis, too little anaesthetic obviously gives one a risk of patient explicit recall and also we may lose the benefits of anaesthetic neuronal protection. So, there is a balance to be struck. Key: the x axis indicates that increasing anaesthetic concentration from low to high has an effect on the risk of awareness and lack of neuronal protection if the concentration is too low (left y axis) or on the other hand excessive cardiovascular depression and risk of neuronal toxicity in the concentration is too high (right y axis).
DEPTH OF ANAESTHESIA MONITOR-ING AS PART OF THE MMM STRAT-EGY
The low-risk patient is indicated by the red line which suggests that there is a wide margin of safety when choosing a suitable anaesthetic concentration and the risk of harm is minimal. This is indicated by the shallowness of the curve. On the other hand, with an elderly or high-risk patient, the implications for getting it wrong as indicated by the blue curves are much greater (steeper curves) and there is a much narrower margin of safety. Conventional wisdom suggests that most elderly or high-risk patients need very little anaesthesia as indicated by the left-hand blue curve. However, there is a wide spectrum of anaesthesia requirements in the elderly or high-risk patient which means that they may require even more anaesthetic than the low-risk patient. Use of a cortical suppression monitor allows us to adjust for these differences and administer the correct amount of anaesthesia for the individual high risk patient.
Reproduced with permission from Perioperative Medicine (ref 8)
The red curve indicates a low risk patient where the target anaesthetic concentration is rather broad and the implications of a small clinical misjudgement of the depth of anaesthesia (as indicated by the shallowness of the curve) means that not too much harm will likely come to the patient. This is not the same situation in the elderly or high-risk patient in whom it is usually assumed that the amount of anaesthetic required is less and too light anaesthesia will lead to the patient waking up and moving around whereas a slight increase to deepen the anaesthetic may result in profound cardiovascular depression. All anaesthetists have observed this in their practice! However, 10 years' experience with the BIS monitor in high-risk patients, especially the elderly, have shown that some older patients require much more anaesthetic than others and indeed there is up to a fourfold variation in propofol anaesthesia requirement. (45) This variation cannot be predicted by clinical signs alone.
EXCESSIVE DEPTH OF ANAESTHESIA IS HARMFUL
This technology is now recommended by NICE in the UK for high-risk patients and the latest Recommendations for Standards of Monitoring during Anaesthesia and Recovery 2015 from the Association of Anaesthetists of Great Britain and Ireland (AAGBI) include depth of anaesthesia monitoring during total intravenous anaesthesia when neuromuscular blockers are used. (51) Evidence shows that BIS guided anaesthesia decreases post-operative delirium (52) and cognitive decline (POCD) (53) and in the USA it is now recommended to reduce the incidence of delirium in older patients. (54) In addition, the latest "Triple Low" study has now confirmed that the combination of hypotension (MAP < 75mmHg) together with a low BIS (<45) and low anaesthesia requirement (MAC < 0.8) is associated with an increase in 30 and 90-day mortality by approximately 10% for every 15 cumulative minutes of triple low states. This was after controlling for known confounders for perioperative death which confirms that a low BIS number is not an epiphenomenon (i.e. as a result of the patient being sick and thus high risk) but is due to excess anaesthetic dose. (55) Depth of anaesthesia monitoring is an essential component of MMM!
USE OF COMBINED BIS AND CER-EBRAL OXIMETRY TO REDUCE THE INCIDENCE OF POCD
In a cohort study and nested randomised controlled trial of high risk elderly patients undergoing major abdominal and orthopaedic surgery, using combined technology of BIS and cerebral oximetry as interventions, investigators were able to show a profound reduction in the intervention group in POCD. (56) Of interest was the fact that maintaining the BIS in the "normal" range 40-60 i.e. not too deep and not too light led to significantly lower levels of S100 B, an indicator of neuronal damage, in the intervention group.
SHOULD WE USE A MMM STRATEGY IN HIGH-RISK PATIENTS?
One of the highest risk patient categories that are dealt with on a routine basis are those elderly patients who suffer a proximal femoral fracture. Recent guidelines suggest that monitoring of CO, depth of anaesthesia and rSO2 should be considered alongside a basic monitoring setup in this high-risk group. (58)
HOW DO WE DO IT?
An in-depth discussion of using MMM is outside the scope of this article. However, the basic strategy and rationale of MMM in reducing oxygen debt is outlined in Figure 3 .
■ LiDCOrapid monitoring is established and this can use either the radial artery invasive or non-invasive arterial BP waveform (CNAP, CN systems, Graz, Austria) ■ Record the baseline values for MAP, nCO and nDO2 ■ Attach BIS monitor to obtain a baseline and commence monitoring ■ Attach cerebral oximeter electrode (s) and obtain a baseline rSO2 prior to preoxygenation ■ Begin a low dose phenylephrine or noradrenaline infusion to maintain venous tone ■ Induce and maintain anaesthesia (BIS 40 -55) using ideally a total intravenous technique using remifentanil and propofol ■ Maintain rSO2 by ensuring an adequate Hb concentration and nDO2 is at least 85% or greater than baseline. NB in the elderly, hypocapnia is one of the commonest reasons for an unexpected decline in rSO2
DOES THE MMM STRATEGY MAKE A DIFFERENCE TO OUTCOME IN HIGH-RISK SURGERY
An observational case series in 120 very high-risk patients undergoing major peripheral vascular surgery suggests that a mean nCO and rSO2 can be maintained at 87% or above of pre-induction value with a mean BIS of 45. The fluid requirement was only 5ml.kg-1.hr-1 30 day mortality was 0.8% (predicted 9%) and major amputation rate was 2% at 1 year. Only 8% of patients required postoperative HDU/ICU. (45) This compares very favourably with the outcome of recent randomised controlled trials using GDFT and SVO as seen in the Table 1 . It is crucial that future randomised controlled trials using flow monitoring should use the MMM approach mentioned above with efforts made to have appropriate levels of cortical suppression and maintain preinduction values of CO and DO2 to within 10 to 15% of baseline. The technique of SV maximisation and GDT to a populationbased target of 600 ml.m-2 BSA should be abandoned. (9) In addition, future trials should recognise that third space loss does not occur in elective major surgery and thus patients should only receive minimal maintenance fluid in addition to replacement of obvious volume losses, a point recognised in the Optimise trial (5) protocol but not in other recent trials. (6, 58)
THE FUTURE
It should become routine practice to use a MMM strategy to try to maintain perioperative DO2 to minimise build-up of oxygen debt as a key for successful outcomes in high-risk surgical patients. This is achievable now with the monitoring tech- 
CONCLUSION
MMM has advantages for the anaesthetist, the patient and the healthcare system.
It pinpoints very clearly the physiological changes associated with anaesthesia and surgery from pre-induction to post anaesthesia care unit. It allows intervention strategies to be more focused and physiologically appropriate and allows a more rational approach to intraoperative haemodynamic management. As we get greater insight into intraoperative physiological change in our patients we can individualise management using strategies designed and centred on minimising the build-up of oxygen debt and thus this should improve outcome. The burgeoning of the elderly high-risk patient population mandates a new perioperative anaesthetic management strategy alongside ERAS. It would appear that MMM reduces the requirement for expensive HDU and ICU facilities and may decrease hospital length of stay and therefore reduce the cost of perioperative care by reducing patient morbidity and mortality. CI, cardiac index GDFT, goal directed fluid therapy SVO/M, stroke volume optimization/maximization. RCT, randomized controlled trial.
Key: As can be seen many of the patients (50 to 80%) were ASA II or less and thus not strictly high risk. Nevertheless, the mortality ranges between 2.2 and 4.9% in the intervention groups. The MMM in vascular surgery trial was not a RCT and the expected mortality was based on V Possum scores. (see reference). Only 1 patient was ASA II the remainder were ASA III or IV.
